Methodology

Articles

• 2018. Guyot P et al. – Number needed to treat in indirect treatment comparison
• 2017. Arnould B – Using patient-reported outcomes as tools for clinical practice: A new paradigm
• 2015. Regnault A et al. – Pooling of cross-cultural PRO data in multinational clinical trials: How much can poor measurement affect statistical power?
• 2015. Regnault A et al. – Using quantitative methods within the Universalist model framework to explore the cross-cultural equivalence of patient-reported outcome instruments
• 2014. Anthoine E et al. – Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures
• 2014. Medic G et al. – Rx to OTC switch. Is this the next big thing?
• 2014. Bredart A et al. – Interviewing to develop Patient-Reported Outcome (PRO) measures for clinical research: Eliciting patients’ experience
• 2013. Cope S et al. – Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making
• 2013. Medic G et al. – Clinical trials and network meta-analysis (NMA): Side by side
• 2012. Jansen JP et al. – Meta-regression models to address heterogeneity and inconsistency in network meta-analysis of survival outcomes
• 2012. Jansen JP et al. – Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons
• 2012. Franchini AJ et al. – Accounting for correlation in mixed treatment comparisons with multi-arm trials
• 2012. Jansen JP – Network meta-analysis of individual and aggregate level data
• 2012. Marant C et al. – Long-term treatment acceptance: What is it and how can it be assessed?
• 2012. Guyot P et al. – Enhanced secondary analysis of survival data: Reconstructing the data from published Kaplan-Meier survival curves
• 2012. Anfray C et al. – Questions of copyright
• 2012. Acquadro C et al. – Linguistic Validation Manual for Health Outcome Assessments
• 2011. Guyot P et al. – Survival time outcomes in randomized, controlled trials and meta-analyses: The parallel universes of efficacy and cost-effectiveness
• 2011. Hoaglin DC et al. – Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2
• 2011. Jansen JP et al. – Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1
• 2011. Jansen JP – Network meta-analysis of survival data with fractional polynomials
• 2011. Patrick DL et al. – Patient-reported outcomes (In: Cochrane Handbook for Systematic Reviews of Interventions)
• 2011. Rofail D et al. – Treatment satisfaction instruments for different purposes during a product’s lifecycle: Keeping the end in mind
• 2010. Lasch K et al. – PRO development: Rigorous qualitative research as the crucial foundation
• 2010. Fleurence RL et al. – The critical role of observational evidence in comparative effectiveness research
• 2010. Ouwens MJ et al. – Network meta-analysis of parametric survival curves
• 2008. Jansen JP et al. – Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons
• 2005. Emery MP et al. – Patient-reported outcome and quality of life instruments database (PROQOLID): Frequently asked questions

Posters & Presentations

• 2017. ISPOR European Congress – Electronic patient-reported outcomes: Are there gaps between guidance and issues encountered in practice?
• 2017. ISPOR European Congress – Gamification, what is it and how can it be used in health outcomes research?
• 2017. PhUSE Annual Conference – Integrated clinical databases to detect safety signals across products and indications
• 2017. ISPOR Latin America Conference – Uses of real world evidence (RWE) in healthcare decision making: Case studies in Argentina, Chile and Colombia
• 2016. ISPOR European Congress – PROQOLID Database: Evolution of Content, Structure, and Functionalities (2012-2016) – Integration in ePROVIDE, a New Online Platform dedicated to Clinical Outcome Assessment (COA) Research
• 2016. ISPOR European Congress – Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation: A Systematic Literature Review
• 2016. ISPOR European Congress – Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods
• 2016. ISPOR European Congress – Development of a Guidance on the Implementation and Use of EORTC Instruments in Electronic Applications
• 2016. ISPOR European Congress – Methods for Analyzing Patient-Reported Outcomes in Oncology Trials
• 2016. ISPOR European Congress – Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using a Mixed Methods Design: An Example in a Rare Cardiac Clinical Trial
• 2016. ISOQOL Annual Conference – Individual Presentation: Conversion Mixed Design: When Quantitative Methods can Contribute to Patient-Centered Qualitative Data Analysis. Included in Symposium 9 – Mixed Methods Research Applied to Patient-Centered Outcomes Research: Perspectives and Case Studies
• 2016. ISOQOL Annual Conference – Patients’ and Healthcare Professionals’ Experiences with a Patient-Controlled Electronic Medical Record and Communication Platform (Patients Know Best® (PKB))
• 2016. ISOQOL Annual Conference – Qualitative Research to Explain Quantitative Results: An Example of Triangulation in the Case of a Rare Cardiac Disease
• 2016. ISOQOL Annual Conference – PROQOLID Database: Evolution of Content, Structure, and Functionalities (2012-2016) – Integration in ePROVIDE, a New Online Platform dedicated to Clinical Outcome Assessment (COA) Research
• 2016. ICPE Meeting – Worldwide Mapping of Generic Sources of RealWorld Data: A Systematic Review
• 2016. MMIRA Conference – How Can Qualitative Data Help Explain Quantitative Results? An Example of Triangulation Analysis in the Case of a Rare Cardiac Disease
• 2016. ISPOR Annual International Meeting – Secondary Analysis of Qualitative Data to Inform the Development of PRO Instruments
• 2016. ISPOR Annual International Meeting – Defining and Capturing Patient-Centred Care in Long-Term Conditions: The Development of a Patient-Reported Experience Measure
• 2015. ISPOR European Congress – The 5-Years European Price Stability Awarded to Innovative Medicines: Is It Verified in Practice?
• 2015. ISPOR European Congress – Moving the Science Forward: Tackling Key Psychometric and Methodological Issues Facing the Field of Clinical Outcome Assessment
• 2015. ISPOR European Congress – Capturing Accurate Concomittant Medications Information in Global Trials
• 2015. ISPOR Latin America Conference – Generando y Utilizando Evidencia en el Mundo Real Para América Latina: Estableciendo Sociedades, Hallando Información, Evaluando Apropriadamente, y Generando Decisiones: Perspectivas Locales, Internacionales, Publicas, y Privadas
• 2015. ISOQOL Annual Conference – Development of a Database of Published Regulatory Recommendations Concerning the Use of Clinical Outcomes Assessments (COAs) in Drug Development: Outcomes InSite
• 2015. ISOQOL Annual Conference – Caring about Caregivers: Definitions, Methods and Importance of Evaluating Caregivers’ Burden
• 2015. ISPOR Latin America Conference – Obstáculos y Buenas Prácticas en el Uso de Evidencia de la Vida Real (RWE) en Argentina, Brasil y México: Desde el Registro a la Diffusión
• 2014. ISPOR European Congress – Integrating the patient perspective in the assessment of benefits and risks of medicines
• 2014. ISPOR European Congress – Can mixed methods research be the solution to the challenges of patient-centered outcome research in the context of rare diseases?
• 2014. ISPOR European Congress – Mixed-methods research within clinical trials: Operational considerations
• 2014. ISPOR European Congress – Extrapolation of trial-based survival curves using external information
• 2014. ISOQOL Annual Conference – Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Integration of the New COA Taxonomy-The ClinRO Example
• 2014. ISOQOL Annual Conference – Conversion Mixed Design: A Promising Mixed Methods Research Approach to Patient-Centered Outcome Questions in Clinical Research
• 2014. MMIRA Annual Conference – A mixed method approach to help demonstrate saturation in qualitative research: applying Partial Least Square regression to qualitative data
• 2014. ISPOR Annual International Meeting – Overview of Patient-Centered Outcome Measures Available in the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID) for Use in Quebec
• 2013. ISPOR European Congress – Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Inclusion of ePRO Information
• 2013. ISPOR European Congress – Comparing the Challenges of Comparative Effectiveness Research in France, Italy and the Netherlands: Current Situation and Perspectives
• 2013. ISPOR European Congress – Direct-To-Patient Contact and Proactive Pharmacovigilance System: A Case Study
• 2013. ISPOR European Congress – The Role of Communication and Health Literacy on Patient Safety in Public Pharmacies in the Republic of Srpska
• 2013. ISOQOL Annual Conference – A Mixed Method Approach to Saturation: Applying Partial Least Square Regression to Qualitative Data
• 2013. ISOQOL Annual Conference – Applying Partial Least Square Regression to Further Explore Concept Structure and Interviewee Profiles in Qualitative Research
• 2013. ISOQOL Annual Conference – Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Inclusion of e-PRO Information
• 2013. ISPOR Latin America Conference – Advances in Meta-Analysis: Incorporating Multiple Treatments, Multiple Endpoints, and Multiple Study Designs
• 2013. ISPOR Annual International Meeting – Direct-To-Patient Study Designs For Pharmacovigilance
• 2012. ISPOR European Congress – Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Evolution of Content, Structure, and Functionalities (2002-2012)
• 2012. ISPOR European Congress – How to Increase Patient Retention Rate during Their Participation in Longitudinal Studies
• 2012. ISPOR European Congress – Reminders Help Improving Completion Rate of Home-Administered Lifestyle Questionnaires
• 2012. ISOQOL Annual Conference – Rasch Measurement: A Mixed Methods Approach for Assessing Content Validity
• 2012. ISPOR European Congress – Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Evolution of Content, Structure, and Functionalities (2001-2012)
• 2012. ISPOR Asia-Pacific Conference – Overview of PRO Instruments from the PROQOLID Database for Use in Taiwan
• 2012. ISCB Annual Conference – Analysis of time to patient-reported outcome meaningful change: Illustration from a clinical trial of catumaxomab in patients with malignant ascites
• 2012. ISCB Annual Conference – Applying partial least squares discriminant analysis (PLS-DA) for optimisation of decision rules based on complex patient-reported data: creation of the FibroDetect® scoring method
• 2012. ISPOR Annual International Meeting – How to select Patient-Reported Outcome (PRO) Measure to Ensure Proper Evaluation of an Observational Study
• 2012. ISPOR Annual International Meeting – PROQOLID Database: Where are We Ten Years after its Launch?
• 2011. ISPOR European Congress – Challenges to Obtain Real-Life Data in Observational Studies: What are the Solutions When the Patient is the Main Data Provider?
• 2011. ISPOR European Congress – An Evaluation of Statistical Methods Used to Analyse Patient-Reported Outcomes (PRO) Data in Published Metastatic Cancer Studies
• 2011. ISOQOL Annual Conference – Pushing the Boundaries of Quality of Life Research: Using Patients’ Words in a Gap Analysis of PRO Measures
• 2011. ISOQOL Annual Conference – Enhancing Quality of Life Research with Qualitative Data
• 2011. ISOQOL Annual Conference – Methods to Achieve, Assess and Document Saturation in Qualitative Research
• 2011. ISOQOL Annual Conference – Patient-Emergent Content Validity: Putting Theory into Practice
• 2011. ICPE Meeting – Direct to patient contact: an added value to follow up patients in observational, longitudinal studies
• 2010. ISPOR Annual International Meeting – Good Research Practices for Comparative Effectiveness Research and Use of Indirect Treatment Comparisons in Health Care Decisions
• 2009. ISPOR European Congress – How to Make Use of Available Survival Evidence in an Indirect Comparison
• 2009. ISPOR European Congress – Post-Reimbursement Studies Assessing Good Medication Use in Real Practice: French Situation
• 2009. ISPOR European Congress – Exploring Patients’ Satisfaction with Anticoagulant Treatment by Applying Structural Equation Models to the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).
• 2008. ISPOR European Congress – Review of Home Readiness Instruments to Assess Recovery Post-Surgery
• 2008. ISPOR Annual International Meeting – When are Indirect and Mixed Treatment Comparisons Biased? A Graphical Explanation with DAGS
• 2008. ISPOR Annual International Meeting – What Patients Say Vs. What Patients Mean: Qualitative Research in PRO Development
• 2006. ISPOR European Congress – Workshop 3: Combining Direct and Indirect Comparisons to Provide Product Value Arguments
• 2005. ISPOR European Congress – Workshop 30: The Value of Conjoint Analysis in Outcomes Research
• 2005. ISPOR European Congress – Workshop 16: The Use of Composite Endpoints: A Review of the Regulators Perspective and Methodological Issues
• 2005. ISPOR European Congress – Workshop 11: The Added Value of Bayesian Belief Networks for Decision Making
• 1999. ISPOR Annual International Meeting – Minimal Standards for the Validation of Quality of Life Instruments Used in Clinical Trials
• 1999. ISPOR Annual International Meeting – The Role of Quality of Life Information in Managed Care Decision-Making
• 1999. ISPOR International Annual Meeting – Workshop WMD1: Data Collection Methods for Resource Utilization: Choosing the Right Approach